Eurofins Scient (OTCMKTS:ERFSF – Get Free Report) and Teladoc Health (NYSE:TDOC – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation.
Analyst Recommendations
This is a summary of recent recommendations for Eurofins Scient and Teladoc Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Eurofins Scient | 0 | 2 | 1 | 0 | 2.33 |
| Teladoc Health | 1 | 12 | 5 | 0 | 2.22 |
Teladoc Health has a consensus target price of $7.53, indicating a potential upside of 14.37%. Given Teladoc Health’s higher probable upside, analysts clearly believe Teladoc Health is more favorable than Eurofins Scient.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Eurofins Scient | N/A | N/A | N/A |
| Teladoc Health | -6.81% | -11.45% | -5.54% |
Insider & Institutional Ownership
76.8% of Teladoc Health shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Risk and Volatility
Eurofins Scient has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 2.08, indicating that its stock price is 108% more volatile than the S&P 500.
Valuation and Earnings
This table compares Eurofins Scient and Teladoc Health”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Eurofins Scient | $8.25 billion | 1.70 | $537.29 million | N/A | N/A |
| Teladoc Health | $2.53 billion | 0.47 | -$200.32 million | ($0.97) | -6.79 |
Eurofins Scient has higher revenue and earnings than Teladoc Health.
Summary
Eurofins Scient beats Teladoc Health on 7 of the 12 factors compared between the two stocks.
About Eurofins Scient
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
About Teladoc Health
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
